These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28283200)

  • 21. Multidrug-resistant organisms and antibiotic management.
    Barie PS
    Surg Clin North Am; 2012 Apr; 92(2):345-91, ix-x. PubMed ID: 22414417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The within-host population dynamics of normal flora in the presence of an invading pathogen and antibiotic treatments.
    Kim J; Lee DH; Song YS; Kang SW; Kim SW
    J Microbiol Biotechnol; 2007 Jan; 17(1):146-53. PubMed ID: 18051366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.
    Gjini E; Brito PH
    PLoS Comput Biol; 2016 Apr; 12(4):e1004857. PubMed ID: 27078624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting virulence for antimicrobial chemotherapy.
    Lee YM; Almqvist F; Hultgren SJ
    Curr Opin Pharmacol; 2003 Oct; 3(5):513-9. PubMed ID: 14559097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
    Medina E; Pieper DH
    Curr Top Microbiol Immunol; 2016; 398():3-33. PubMed ID: 27406189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Technologies to address antimicrobial resistance.
    Baker SJ; Payne DJ; Rappuoli R; De Gregorio E
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):12887-12895. PubMed ID: 30559181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host-directed drug targeting of factors hijacked by pathogens.
    Schwegmann A; Brombacher F
    Sci Signal; 2008 Jul; 1(29):re8. PubMed ID: 18648074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When Humans Met Superbugs: Strategies to Tackle Bacterial Resistances to Antibiotics.
    Bravo A; Ruiz-Cruz S; Alkorta I; Espinosa M
    Biomol Concepts; 2018 Dec; 9(1):216-226. PubMed ID: 30811343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What if there were no new antibiotics? A look at alternatives.
    Rello J; Bunsow E; Perez A
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1547-1555. PubMed ID: 27678160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophils and Immunity: From Bactericidal Action to Being Conquered.
    Teng TS; Ji AL; Ji XY; Li YZ
    J Immunol Res; 2017; 2017():9671604. PubMed ID: 28299345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating research on bacterial pathogens and commensals to fight infections-an ecological perspective.
    Maier L; Stein-Thoeringer C; Ley RE; Brötz-Oesterhelt H; Link H; Ziemert N; Wagner S; Peschel A
    Lancet Microbe; 2024 Aug; 5(8):100843. PubMed ID: 38608681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
    Dickey SW; Cheung GYC; Otto M
    Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
    Guillard T; Pons S; Roux D; Pier GB; Skurnik D
    Bioessays; 2016 Jul; 38(7):682-93. PubMed ID: 27248008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-directed therapies for bacterial and viral infections.
    Kaufmann SHE; Dorhoi A; Hotchkiss RS; Bartenschlager R
    Nat Rev Drug Discov; 2018 Jan; 17(1):35-56. PubMed ID: 28935918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Virulence Strategy against the Multidrug-Resistant Bacterial Pathogen Pseudomonas aeruginosa: Pseudolysin (Elastase B) as a Potential Druggable Target.
    Galdino ACM; de Oliveira MP; Ramalho TC; de Castro AA; Branquinha MH; Santos ALS
    Curr Protein Pept Sci; 2019; 20(5):471-487. PubMed ID: 30727891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-bacterial Monoclonal Antibodies.
    Nagy E; Nagy G; Power CA; Badarau A; Szijártó V
    Adv Exp Med Biol; 2017; 1053():119-153. PubMed ID: 29549638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection.
    Hong-Geller E; Micheva-Viteva SN
    Curr Drug Discov Technol; 2010 Jun; 7(2):86-94. PubMed ID: 20836760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.